Skip to main content

Table 3 Second-line drugs resistance profile DR-TB patients without and with DM.

From: The differences in drug resistance between drug-resistant tuberculosis patients with and without diabetes mellitus in northeast China: a retrospective study

Drugs resistance pattern

No DM, N (%)

DM, N (%)

Any resistance to second-line drugs

  

Any PTO

6 (1.83)

10 (5.38)

Any PAS

19 (5.81)

8 (4.30)

Any AM

23 (7.03)

6 (3.23)

Any CM

13 (3.98)

9 (4.84)

Any KM

25 (7.65)

5 (2.69)

Any LFX

50 (15.29)

35 (18.82)

Any OFX

51 (15.60)

25 (13.44)

Monoresistant second-line drugs

  

PTO

1 (0.31)

3 (1.61)

PAS

4 (1.22)

4 (2.15)

AM

1 (0.31)

0 (0)

CM

1 (0.31)

3 (1.61)

KM

2 (0.61)

2 (1.08)

LFX

9 (2.75)

12 (6.45)

OFX

10 (3.06)

7 (3.76)

Pre-XDR-TB

24 (7.34)

26 (13.98)

XDR-TB

16 (4.89)

5 (2.69)

  1. Abbreviations: PTO, protionamide; PAS, para-aminosalicylic acid; AM, amikacin; CM, capreomycin; KM, kanamycin; LFX, levofloxacin; OFX, ofloxacin; XDR-TB, extensively drug-resistant TB; DM, diabetes mellitus.